Espec Corp. AI Stock Analysis
Want to see JP:6859 full AI Analyst Report?
Espec Corp. (6859) AI Stock Analysis
Espec Corp.
(TSE/TYO:6859)
The score is driven primarily by strong financial performance—especially the low-leverage balance sheet and improved profitability—tempered by uneven cash-flow conversion and mild margin pressure signs in 2026. Technicals are supportive with price above key moving averages and positive MACD, while valuation is reasonable with a moderate P/E and a ~2.65% dividend yield.
Espec Corp. (6859) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 77.47B
- Dividend Yield
- 3.09%
- Average Volume (3M)
- 102.24K
- Price to Earnings (P/E)
- 13.3
- Beta (1Y)
- 1.23
- Revenue Growth
- 7.92%
- EPS Growth
- 11.54%
- Country
- Japan
- Employees
- 1,898
- Sector
- General
- Sector Strength
- 55
- Industry
- Hardware, Equipment & Parts
Espec Corp. Business Overview & Revenue Model
Company Description
Espec Corp. is a global producer and distributor of environmental testing equipment. The company's business activities are organized into three primary divisions: Equipment Business, Service Business, and Other Business. Its product line features a w...
Espec Corp. Financial Statement Overview
Summary
Strong overall fundamentals: steady multi-year revenue growth and improved profitability versus earlier years, supported by a very conservative balance sheet with low and declining leverage. Key offsets are uneven cash-flow conversion (notably a weak 2024) and signs of margin pressure in 2026 as profits dipped slightly despite higher revenue.
Income Statement
78PositiveBalance Sheet
92Very PositiveCash Flow
70Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 71.63B | 70.03B | 67.29B | 62.13B | 52.89B | 41.85B |
| Gross Profit | 24.60B | 24.04B | 23.73B | 21.80B | 17.83B | 13.90B |
| EBITDA | 9.31B | 9.30B | 9.50B | 8.30B | 5.83B | 3.37B |
| Net Income | 5.93B | 5.88B | 6.00B | 4.97B | 3.33B | 1.91B |
Balance Sheet | ||||||
| Total Assets | 80.37B | 82.92B | 75.85B | 78.23B | 67.18B | 61.92B |
| Cash, Cash Equivalents and Short-Term Investments | 19.03B | 14.70B | 12.77B | 16.80B | 14.30B | 16.16B |
| Total Debt | 461.00M | 611.00M | 1.05B | 5.30B | 712.00M | 958.00M |
| Total Liabilities | 20.59B | 21.52B | 19.15B | 25.52B | 20.00B | 16.33B |
| Stockholders Equity | 59.78B | 61.40B | 56.69B | 52.72B | 46.95B | 45.38B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 3.65B | 2.26B | 498.00M | 947.00M | 1.34B |
| Operating Cash Flow | 0 | 5.05B | 4.45B | 2.74B | 1.92B | 2.02B |
| Investing Cash Flow | 0 | -273.00M | -1.15B | -3.78B | -1.06B | -932.00M |
| Financing Cash Flow | 0 | -3.88B | -7.25B | 2.80B | -2.90B | -2.83B |
Espec Corp. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6859, the sentiment is Negative. The current price of 3720.00 is below the 20-day moving average (MA) of 4127.25, below the 50-day MA of 4088.14, and below the 200-day MA of 3783.53, indicating a bearish trend. The MACD of -144.79 indicates Positive momentum. The RSI at 39.61 is Neutral, neither overbought nor oversold. The STOCH value of 36.84 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6859.
Espec Corp. Peers Comparison
Overall Rating
JP:685980Outperform
JP:686378Outperform
JP:685072Outperform
JP:685668Neutral
JP:686663Neutral
JP:685360Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 80Outperform | JPY 83.22B | 13.33 | ― | 3.09% | 7.92% | 11.54% | |
| 78Outperform | JPY 20.82B | 15.64 | ― | 6.88% | 12.36% | 12.83% | |
| 72Outperform | JPY 31.79B | 12.06 | ― | 2.79% | 6.98% | 38.45% | |
| 68Neutral | JPY 862.88B | 20.10 | 13.84% | 2.52% | 15.90% | 30.50% | |
| 63Neutral | JPY 117.91B | 15.05 | ― | 2.55% | 16.76% | 35.84% | |
| 60Neutral | JPY 18.76B | 26.99 | ― | 2.93% | -3.37% | -32.05% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:6859 | Espec Corp. | 3720.00 | 481.91 | 14.88% | |
| JP:6856 | Horiba | 20595.00 | 6373.03 | 44.81% | |
| JP:6850 | Chino Corporation | 1793.00 | 470.53 | 35.58% | |
| JP:6853 | Kyowa Electronic Instruments Co., Ltd. | 735.00 | 96.10 | 15.04% | |
| JP:6863 | Nireco Corporation | 988.00 | 388.19 | 64.72% | |
| JP:6866 | Hioki E.E.Corporation | 8640.00 | 3045.88 | 54.45% |
Espec Corp. Corporate Events
ESPEC Revises Fiscal 2027 Forecasts, Raises Sales and Orders Outlook
ESPEC Corp., listed on the Tokyo Stock Exchange’s Prime Market under code 6859, revised its consolidated forecasts for the fiscal year ending March 31, 2027. It lifted projected net sales to ¥75.0 billion from ¥73.0 billion, while leaving operating p...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 16, 2026
